Clinical trialNCT02322775CompletedPhase 3Interventional

Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma

SponsorAstraZenecaEnrollment211Asthma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Gary T. Ferguson, M.D.,P.C.
Pulmonary Research Institute of Southeast Michigan
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

57 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

Research Site
Vancouver, British Columbia, Canada
Research Site
Ajax, Ontario, Canada
Research Site
Burlington, Ontario, Canada
Research Site
Hamilton, Ontario, Canada
Research Site
Ottawa, Ontario, Canada
Research Site
Toronto, Ontario, Canada
Research Site
Québec, Quebec, Canada
Research Site
Québec, Quebec, Canada
Research Site
Saint-Charles-Borromée, Quebec, Canada
Research Site
Trois-Rivières, Quebec, Canada

Germany

Research Site
Bamberg, Germany
Research Site
Berlin, Germany
Research Site
Frankfurt, Germany
Research Site
Frankfurt am Main, Germany
Research Site
Hanover, Germany
Research Site
Neu-Isenburg, Germany

Hungary

Research Site
Balassagyarmat, Hungary
Research Site
Komárom, Hungary
Research Site
Miskolc, Hungary
Research Site
Pécs, Hungary
Research Site
Pécs, Hungary
Research Site
Százhalombatta, Hungary

Poland

Research Site
Katowice, Poland
Research Site
Mrągowo, Poland
Research Site
Ostrów Wielkopolski, Poland
Research Site
Pabianice, Poland
Research Site
Poznan, Poland
Research Site
Poznan, Poland
Research Site
Tarnów, Poland
Research Site
Wroclaw, Poland
Research Site
Wroclaw, Poland

Slovakia

Research Site
Bratislava, Slovakia
Research Site
Bratislava, Slovakia
Research Site
Humenné, Slovakia
Research Site
Košice, Slovakia
Research Site
Levice, Slovakia
Research Site
Poprad, Slovakia
Research Site
Prešov, Slovakia
Research Site
Vráble, Slovakia
Research Site
Žilina, Slovakia

17 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 2 Feb 2015
Primary completion: 7 Oct 2015
Completion: 7 Oct 2015
Last update posted: 15 Aug 2017
Registered enrollment: 211
Registry id: NCT02322775

Cross-registrations

EU-CTR / CTIS (EudraCT)2014-004427-40

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.